What We Do
Eascra Biotech is a nanomedicine company that provides precision therapeutic delivery for hard-to-penetrate tissues like articular cartilage, kidneys, and ECM-rich solid tumors. Our groundbreaking, proprietary Janus base nanoparticles (JBNps) are a DNA-inspired synthetic molecule (non-lipid) that fully encapsulates a cargo rendering it room temperature stable while maintaining bioactivity for extended periods. JBNps can deliver a variety of therapeutic cargoes including siRNA, mRNA, cas 9, proteins, peptides, and other drug agents.
Our initial business use cases include treatments for osteoarthritis, cartilage regeneration, and direct therapeutic delivery into solid tumors with reduced systemic exposure for reduced patient side effects. Our JBNps are a versatile, elegant delivery option for your therapeutic needs. For questions regarding your specific delivery requirements, please contact us at info@eascrabiotech.com
Read our business overview here.
Our Product Areas Include
JBNp™, a new delivery platform for mRNA therapeutics and gene editing that can successfully pass through “difficult-to-infiltrate” tissue barriers. JBNp™ is room-temperature stable.
JBNm™ is a revolutionary cell-free injectable scaffold for use in orthopedic applications involving cartilage repair and regeneration.
JBNm-Tissue Chip™ simulates knee joints on a microchip for accelerated biomedical research and drug testing.
Current Partners
